检索结果-南通市图书馆

association between ICU quality and in-hospital mortality of V-V ECMO-supported patients—the ECMO quality improvement action(EQIA)study:a national cohort study in china from 2017 to 2019

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Frontiers of Medicine 2024年第2期18卷 315-326页

作者： Wei Cheng Jieqing Chen Xudong Ma Jialu Sun Sifa Gao Ye Wang Longxiang Su Lu Wang Wei Du Huaiwu He Yujie Chen Zunzhu Li Qi Li Jianhua Sun Hongbo Luo Jinbang Liu Guangliang Shan Bing Du Yanhong Guo Dawei Liu Chang Yin Xiang Zhou on behalf of the china National Critical Care quality Control Center-the ECMO quality improvement action(EQIA)study Department of Critical Care Medicine State Key Laboratory of Complex Severe and Rare DiseasesPeking Union Medical College HospitalChinese Academy of Medical Science and Peking Union Medical CollegeBeijing100730China Information Center Department/Department of Information Management State Key Laboratory of Complex Severe and Rare DiseasesPeking Union Medical College HospitalPeking Union Medical College&Chinese Academy of Medical SciencesBeijing100730China Department of Medical Administration National Health Commission of the People’s Republic of ChinaBeijing100044China School of Population Medicine and Public Health Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing100730China Department of Epidemiology and Biostatistics Institute of Basic Medicine SciencesChinese Academy of Medical Sciences(CAMS)&School of Basic MedicinePeking Union Medical CollegeBeijing100730China National Institute of Hospital Administration National Health Commission of the People’s Republic of ChinaBeijing100044China 不详

This cohort study was performed to explore the influence of intensive care unit(ICU)quality on in-hospital mortality of veno-venous(V-V)extracorporeal membrane oxygenation(ECMO)-supported patients in *** study involved all V-V ECMO-supported patients in 318 of 1700 tertiary hospitals from 2017 to 2019,using data from the National Clinical Improvement System and china National Critical Care quality Control *** quality was assessed by quality control indicators and capacity *** the 2563 V-V ECMO-supported patients in 318 hospitals,a significant correlation was found between ECMO-related complications and *** reintubation rate within 48 hours after extubation and the total ICU mortality rate were independent risk factors for higher in-hospital mortality of V-V ECMO-supported patients(cutoff:1.5%and 7.0%;95%confidence interval:1.05–1.48 and 1.04–1.45;odds ratios:1.25 and 1.23;P=0.012 and P=0.015,respectively).Meanwhile,the V-V ECMO center volume was a protective factor(cutoff of≥50 cases within the 3-year study period;95%confidence interval:0.57–0.83,odds ratio:0.69,P=0.0001).The subgroup analysis of 864 patients in 11 high-volume centers further strengthened these ***,ICU quality may play an important role in improving the prognosis of V-V ECMO-supported patients.

关键词： veno-venous extracorporeal membrane oxygenation in-hospital mortality high-volume centers quality control intensive care unit capacity parameters

2023 Chinese national clinical practice guideline on diagnosis and management of ulcerative colitis

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

中华医学杂志(英文版) 2024年第14期137卷 1642-1646页

作者： Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical association Inflammatory Bowel Disease quality Control Center of china Inflammatory Bowel Disease Group Chinese Society of Gastroenterology Chinese Medical Association Inflammatory Bowel Disease quality Control Center of china

The role of Chinese expert consensus in standardization and improvement of the clinical diagnosis and treatment of inflammatory bowel disease (IBD) is self-evident. As clinical and basic research in china becomes standardized under a better understanding of IBD, more data on Chinese patients have become available to develop a consensus and guideline. This guideline, collaboratively developed by the IBD Group, Chinese Society of Gastroenterology, incorporates the latest international consensus statements, domestic research findings, and practical considerations, as an update based on the 2018 Chinese consensus on IBD management. The IBD guideline consists of two parts: ulcerative colitis (UC) and Crohn's disease, and this manuscript presented the UC part. The evidence used in this guideline was collected and analyzed by the standard of guideline, and the contents were organized as problem statements, for clarity. The formulation of this guideline aimed to reflect the latest progress in IBD, providing comprehensive and valuable guidance for the clinical management of IBD.

关键词：

同方期刊数据库

眼底彩照标注与质量控制规范(T/CAQI 166-2020)

在线全文

学校读者我要写书评

暂无评论

中华实验眼科杂志 2021年第9期39卷 761-768页

作者：中国质量检验协会张秀兰许言午杨卫华中国质量检验协会

前言本文件按照GB/T 1.1-2020《标准化工作导则第1部分:标准化文件的结构和起草规则》的规定起草。请注意本文件的某些内容可能涉及专利。本文件的发布机构不承担识别专利的责任。本标准由中国质量检验协会提出并归口。本标准起草单位:... 详细信息

前言本文件按照GB/T 1.1-2020《标准化工作导则第1部分:标准化文件的结构和起草规则》的规定起草。请注意本文件的某些内容可能涉及专利。本文件的发布机构不承担识别专利的责任。本标准由中国质量检验协会提出并归口。本标准起草单位:中山大学中山眼科中心、北京百度网讯科技有限公司、南京医科大学附属眼科医院、广东省医疗器械质量监督检验所、中国信息通信研究院、南方科技大学、深圳市眼科医院、北京康夫子健康技术有限公司、湖州师范学院、复旦大学附属眼耳鼻喉科医院、河南省眼科研究所、潍坊医学院附属医院、浙江大学-浙大睿医人工智能研究中心、浙江大学医学院附属第一医院、西南医科大学附属医院、温州医科大学附属眼视光医院、孝感市中心医院、贵州航天医院、赣州市南康区第一人民医院、湖南省益阳市中心医院、深圳市南山区蛇口人民医院、中山大学附属第八医院、江西省南城县人民医院、甘肃省康复中心医院、南京航空航天大学、南京医科大学、福建省立医院南院。

关键词：标准化工作导则南方科技大学人工智能研究福建省立医院潍坊医学院康复中心眼科医院湖南省益阳市

维普期刊数据库

2023 Annual Report of china's Paper Industry

在线全文

学校读者我要写书评

暂无评论

造纸信息 2024年第10期 134-146页

作者： china Paper association china Paper association

According to statistics, the total production of pulp, paper & board, paper products was 291.39 million tons in 2023, increased by 2.63% year-on-year. In which, the production of paper & board was 129.65 million tons, increased by 4.35% compared with the previous year; the production of pulp was 88.23 million tons, increased by 2.75% compared with the previous year; the production of paper products was 73.51 million tons, decreased by 0.38% compared with the previous year. The industry's operating income was CNY 1.39 trillion, decreased by 2.39% compared with the previous year; the total profit was CNY 50.8 billion, increased by 4.39% compared with the previous year.

关键词：

来源：博看期刊

Helping Chinese Brands Go Global

在线全文

学校读者我要写书评

暂无评论

china Today 2024年第7期73卷 60-61页

作者： INTERNATIONAL COMMUNICATION COMMITTEE OF THE china ADVERTISING association INTERNATIONAL COMMUNICATION COMMITTEE OF THE china ADVERTISING association

The activity organized by Navigator has enhanced Chinese enterprises’understanding of the strategy of brands going *** is a research institute built by the International Communication Committee(ICC)of the china Advertising association devoted to assisting Chinese brands go *** first activity was held at Huawei's headquarters in Shenzhen,aimed at helping the internationalization of Chinese brands.

关键词： Brand enterprises devoted

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

妊娠合并子宫颈癌诊治指南（2024年版）

中国实用妇科与产科杂志 2024年第10期 1003-1012页

作者： Cervical Cancer Committee of china Anti-Cancer association Obstetrics and Gynecology Society of Chinese Medical Doctor association 中国抗癌协会宫颈癌专业委员会中国医师协会妇产科医师分会

1引言子宫颈癌是中国发病率最高的女性生殖道恶性肿瘤，同时也是妊娠期最常见的恶性肿瘤之一，发生率为（1.5～12）例/10万次妊娠，约占所有妊娠期恶性肿瘤的10%[1-3]，多数患者确诊时处于Ⅰ期[4-5]。在过去的10年中，我国妊娠合并子宫... 详细信息

1引言子宫颈癌是中国发病率最高的女性生殖道恶性肿瘤，同时也是妊娠期最常见的恶性肿瘤之一，发生率为（1.5～12）例/10万次妊娠，约占所有妊娠期恶性肿瘤的10%[1-3]，多数患者确诊时处于Ⅰ期[4-5]。在过去的10年中，我国妊娠合并子宫颈癌的发病率有所增高，主要与高龄妊娠的增加密切相关[6]。关于妊娠合并子宫颈癌的定义，广义是指妊娠期至分娩后6～12个月内新确诊的子宫颈癌，狭义是仅限定在妊娠期发现的子宫颈癌。

关键词：妊娠子宫颈癌指南

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

百乐眠胶囊治疗失眠症临床应用专家共识

中国中药杂志 2024年第20期 5635-5642页

作者： Expert Group of Psychosomatic Medicine Branch of china association of Chinese Medicine 中华中医药学会心身医学分会专家组

百乐眠胶囊作为适用于阴虚火旺型失眠症的中成药，目前被广泛应用于短期失眠症、慢性失眠症及卒中后失眠、失眠伴焦虑抑郁状态等心身疾病，并被多项共识/指南/路径推荐。该共识在专家访谈、问卷调研和百乐眠胶囊文献系统回顾的基础上，... 详细信息

百乐眠胶囊作为适用于阴虚火旺型失眠症的中成药，目前被广泛应用于短期失眠症、慢性失眠症及卒中后失眠、失眠伴焦虑抑郁状态等心身疾病，并被多项共识/指南/路径推荐。该共识在专家访谈、问卷调研和百乐眠胶囊文献系统回顾的基础上，遵循“循证为举，共识为主，经验为鉴”原则，总结现有最佳证据，充分结合专家经验以及患者偏好，基于百乐眠胶囊自身特点及临床实际，形成了百乐眠胶囊单用和联合西药用于治疗失眠症、慢性失眠症伴焦虑抑郁状态、特殊人群失眠症等7条推荐意见和12条共识建议。共识起草过程中，通过线上与线下相结合的征求意见方式，在全国范围内进行了征求意见和同行评议。该共识适用于各级医院的中医、西医和中西医结合医师，基层卫生服务机构的临床医师，为其合理使用百乐眠胶囊提供指导和参考。旨在指导和规范临床医生合理使用百乐眠胶囊，提高临床疗效和安全性。该共识已通过中华中医药学会审核发布，编号GS/CACM 329-2023。

关键词：百乐眠胶囊专家共识失眠症循证医学中医药

同方期刊数据库

Evidence-based expert consensus on clinical management of safety of Bruton’s tyrosine kinase inhibitors(2024)

在线全文

学校读者我要写书评

暂无评论

Chinese Journal of Cancer Research 2024年第3期36卷 240-256页

作者： Zaiwei Song Dan Jiang Lingling Yu Yixuan Chen Daobin Zhou Yue Li Depei Wu Lingli Zhang Liyan Miao Jun Ma Jun Zhu Hongmei Jing Rongsheng Zhao the Steering Committee,the Consensus Panel and the Evidence Synthesis Group Evidence-based Pharmacy Professional Committee of Chinese Pharmaceutical association(CPA) Hospital Pharmacy Professional Committee of Chinese Pharmaceutical association(CPA) Division of Therapeutic Drug Monitoring of Chinese Pharmacological Society(CPS) Expert Committee on Lymphoma of Chinese Society of Clinical Oncology(CSCO) Expert Committee on Leukemia of Chinese Society of Clinical Oncology(CSCO) Society of Integrative Cardio-Oncology of china Anti-Cancer association(CACA) Chinese Society of Hematology of Chinese Medical association(CMA) Hospital Pharmacy Professional Committee of Cross-Straits Medicine Exchange association(SMEA) Department of Pharmacy Peking University Third HospitalBeijing 100191China Institute for Drug Evaluation Peking University Health Science CenterBeijing 100191China Therapeutic Drug Monitoring and Clinical Toxicology Center Peking UniversityBeijing 100191China Department of Pharmacy Administration and Clinical Pharmacy School of Pharmaceutical SciencesPeking UniversityBeijing 100191China Department of Hematology Peking Union Medical College HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100005China Department of Cardiology the First Affiliated HospitalHarbin Medical UniversityHarbin 150001China Department of Hematology the First Affiliated Hospital of Soochow UniversitySuzhou 215006China Department of Pharmacy Evidence-based Pharmacy CenterWest China Second HospitalSichuan UniversityChengdu 610041China Department of Pharmacy the First Affiliated Hospital of Soochow UniversitySuzhou 215006China Department of Hematology and Oncology Harbin Institute of Hematology and OncologyHarbin 150010China Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing) Department of LymphomaPeking University Cancer Hospital&InstituteBeijing 100142China Department of Hematology Peking University Third HospitalBeijing 100191China 不详

Bruton’s tyrosine kinase inhibitors(BTKis)have revolutionized the treatment of B-cell ***,safety issues related to the use of BTKis may hinder treatment continuity and further affect clinical efficacy.A comprehensive and systematic expert consensus from a pharmacological perspective is lacking for safety issues associated with BTKi treatment.A multidisciplinary consensus working group was established,comprising 35 members from the fields of hematology,cardiovascular disease,cardio-oncology,clinical pharmacy,and evidencebased *** evidence-based expert consensus was formulated using an evidence-based approach and the Delphi *** Joanna Briggs Institute Critical Appraisal(JBI)tool and Grading of Recommendations Assessment,Development,and Evaluation(GRADE)approach were used to rate the quality of evidence and grade the strength of recommendations,*** consensus provides practical recommendations for BTKis medication based on nine aspects within three domains,including the management of common adverse drug events such as bleeding,cardiovascular events,and hematological toxicity,as well as the management of drug-drug interactions and guidance for special *** multidisciplinary expert consensus could contribute to promoting a multi-dimensional,comprehensive and standardized management of BTKis.

关键词： Consensus BTK inhibitors safety adverse drug events drug-drug interactions

维普期刊数据库

Expert consensus on radiotherapy combined with immunotherapy for esophageal cancer(2024 edition)

在线全文

学校读者我要写书评

暂无评论

Radiation Medicine and Protection 2024年第2期5卷 59-67页

作者： Professional Committee of Radiation Oncology china Anti-Cancer association Branch of Radiation Oncology Chinese Medical association Branch of Radiation Oncology TreatmentPhysician Chinese Medical Doctor association Qingsong Pang Jun Wang Zhouguang Hui Wencheng Zhang 不详 Tianjin Medical University Cancer Institute&Hospital Tianjin 300060China the Fourth Hospital of Hebei Medical University Shijiazhuang 050011China National Cancer Center National Clinical Research Center for CancerCancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing 100021China Tianjin Medical University Cancer Hospital China

Radiotherapy represents an essential treatment approach for esophageal *** recent years,immunotherapy combined with chemotherapy has become the first-line standard treatment for patients with advanced esophageal *** phase III studies on immunotherapy combined with radiotherapy for locally advanced esophageal cancer are currently *** evidence-based medical data are urgently needed to support the integration of immunotherapy and chemoradiotherapy as a new treatment strategy for patients with locally advanced esophageal *** consensus,formulated based on the latest study results,in-depth research,and thorough discussions,provides a comprehensive set of *** document extensively covers treatment strategies and evaluation methods for radiotherapy combined with immunotherapy across patients with operable esophageal cancer,inoperable locally advanced esophageal cancer,and advanced esophageal ***,common complications and radiation-related issues associated with radiotherapy combined with immunotherapy are discussed,serving as clinical *** expert group comprised members from the Professional Committee of Radiation Oncology,china Anti-Cancer association,the Branch of Radiation Oncology,Chinese Medical association,and the Branch of Radiation Oncology Treatment Physician,Chinese Medical Doctor association.

关键词： Esophageal squamous cell carcinoma Esophageal adenocarcinoma Immunotherapy Chemoradiotherapy Radiotherapy Expert consensus